POSTER SESSION IV
Tuesday, March 27, 2007 — 1:00 PM - 4:30 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
58
Renal Oncocytoma with Renal Vein Extension
(687)
O Hes, M Michal, R Sima, N Kuroda, G Martignoni, M Brunelli, I Alvarado Cabrero, M Hora, X Yang - Charles University Hospital, Plzen, Czech Republic; Red Cross Hospital, Kochi, Japan; University Verona, Verona, Italy; Centro Medico, Mexico City, Mexico; Northwestern University, Chicago, IL
Heterogeous and Differential Immunohistochemical Staining in Chromphobe Renal Cell Carcinoma and Oncocytoma: A Tissue Microarray Study
(610)
A Awamleh, S Evren, JM Sweet - University Health Network, Toronto, ON, Canada
MITF/TFE Renal Carcinomas. Clinico-Pathologic and Genetic Analysis of 31 Cases
(627)
P Camparo, V Vassiliu, M Lae, V Molinie, M Sibony, J Couturier, A Vieillefond - Val de Grace, France; Necker, France; Curie, France; Saint Joseph, France; Cochin, Paris, France
Renal Tubular Epithelial Dysplasia in Sporadic Clear Cell Renal Cell Carcinoma and CCRCC with Associated Von Hippel Lindau Disease
(662)
AB Frey, C Nijwaji, M Che, W Sakr, D Grignon - Karmanos Cancer Institute, Detroit Medical Center and Wayne State University, Detroit, MI
Sporadic Clear Cell Renal Cell Carcinoma Commonly Expresses Cytokeratin 7 in Cystic Foci: A Morphologic and Immunohistochemical Study with Emphasis on the Relationship To Clear Cell-Papillary Renal Cell Carcinoma of End-Stage Kidney
(638)
WJ Clingan, LA Cerilli, N Gokden, JK McKenney - University of Arkansas for Medical Sciences, Little Rock, AR; University of New Mexico Health Sciences Center, Albuquerque, NM
Evaluation of Expression of Human Kidney Injury Molecule-1 (hKIM-1), P504S, S100, Vimentin and EMA in Renal Cystic Lesions
(798)
J Shi, XJ Yang, PL Zhang, ST Chuang, H Hwang, C Luan, WK Han, JV Bonventre, F Lin - Geisinger Medical Center, Danville, PA; Northwestern Memorial Hospital, Chicago, IL; Brigham and Women[apos]s Hospital, Boston, MA
Expression of Cytokeratins and E-Cadherin Provides a Novel Molecular Subclassification of Clear Cell Renal Cell Cancer
(743)
KD Mertz, F Demichelis, MS Hirsch, H Moch, MA Rubin - Brigham and Women’s Hospital, Boston, MA; University Hospital Zurich, Zurich, Switzerland
Expression of Phospho-mTOR in Different Renal Cell Carcinoma Subtypes Using Tissue Microarrays
(770)
A Petit, A Gaspa, X Garcia-Albéniz, B Mellado, I Nayach, L Gelabert, L Pla, C Mallofré - Hospital Clínic, Barcelona, Spain
Diagnostic and Prognostic Utility of Cyclin D1, Cyclin D3, Cyclin E, P27, MUC1, CD44, CK7 and CK20 in Renal Cell Carcinoma
(705)
S Kiremitci, O Tulunay, S Baltaci, O Gogus - Medical School of Ankara University, Ankara, Sihhiye, Turkey
Differential VHL Immunohistochemical Staining in Clear Cell Renal Cell Carcinoma: Evidence for Differing Mechanisms of VHL Inactivation as a Function of Fuhrman Grade and Clinical Behavior
(685)
PC Henry, A Saravanan, N Burry, M Ohh, AJ Evans - University Health Network, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada
Overexpression of Toll-Like Receptor 3 in Clear Cell Renal Cell Carcinoma: A Potential Therapeutic and Diagnostic Target
(745)
T Morikawa, A Sugiyama, H Kume, K Tomita, T Kitamura, S Ota, M Fukayama, T Kodama, H Aburatani - Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan; Perseus Proteomics Inc, Tokyo, Japan; University of Tokyo Hospital, Tokyo, Japan; Graduate School of Medicine, University of Tokyo, Tokyo, Japan
Expression of Platelet Derived Growth Factor Receptor a and β in 175 Renal Cell Neoplasms Using Tissue Microarrays
(667)
A Gaspa, A Petit, I Nayach, B Mellado, X García-Albéniz, C Mallofré - Hospital Clinic, Barcelona, Spain
Expression of Claudins 1, 4 and 7 in Human Renal Tumors
(715)
M Lechpammer, W Greaves, E Sabo, E Yakirevich, R Tavares, L Noble, MB Resnick, LJ Wang - Rhode Island Hospital, Brown University, Providence, RI
Upregulation of Both Decoy Receptor 1 and c-FLIP May Counteract the Function of DR5 in Renal Cell Carcinoma
(839)
B Yang, N Chen, H Zeng, R Huang, YT Zhang, XQ Chen, YD Huang, Q Zhou - West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China
MDM2 Amplification Is an Uncommon Oncogenic Mechanism in Sarcomatoid Renal Cell Carcinoma: Biologic and Diagnostic Implications
(692)
CM Ida, JC Cheville, WR Sukov, MR Erickson-Johnson, X Wang, AM Oliveira - Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Mayo Clinic, Rochester, MN
Expression of Carbonic Anhydrase IX in Renal Neoplasms: Implications for Use as Diagnostic Marker
(848)
M Zhou, C Magi-Galluzzi - Cleveland Clinic, Cleveland, OH
Detection of Residual Tumor Cells in Bladder Biopsy Specimens: Pitfalls in the Interpretation of Cytokeratin Stains
(814)
EF Tamas, JI Epstein - Johns Hopkins Hospital, Baltimore, MD
Role of Urovysion™ Fluorescence In-Situ Hybridization in the Evaluation of Atypical Urine Cytology from Patients under Surveillance for Recurrent Bladder Cancer
(646)
R Dhir, AV Parwani, R Balassanian, SI Bastacky, R Hrebinko, M Franks, K Cieply, C Vrbin, S Raab - University of Pittsburgh, Pittsburgh, PA
Comparison of Urovysion™ Testing, Conventional Cytology and Surgical Biopsy in Evaluation for Recurrent Bladder Cancer
(645)
R Dhir, AV Parwani, R Balassanian, R Hrebinko, M Franks, SI Bastacky, C Vrbin, S Raab - University of Pittsburgh, Pittsburgh, PA
Positive Urovysion FISH Due to Isolated Loss of 9p21: Comparison with FISH Positive Bladder Tumors Due to Aneuploidy
(641)
MN De Peralta-Venturina, R Kanhere, NS Goldstein - William Beaumont Hospital, Royal Oak, MI
Detection of Bladder Cancer by Proteomics of Urine
(736)
T Majewski, PE Spiess, J Bondaruk, C Clarke, WF Benedict, CPN Dinney, HB Grossman, KS Tang, KA Baggerly, B Czerniak - The University of Texas M. D. Anderson Cancer Center, Houston, TX; Ciphergen Biosystems, Inc, Fremont, CA
LAMC2 mRNA and Protein Expression in Carcinoma of the Bladder
(804)
SC Smith, HF Frierson, D Theodorescu - University of Virginia Health System, Charlottesville, VA
Aberrations of Chromosome 9 Detected by Fluorescence In Situ Hybridization in Urothelial Carcinoma In Situ: Correlation with p16INK4 Immunohistochemical Expression
(841)
M Yin, K Cieply, K Cumbie, S Bastacky, R Dhir - University of Pittsburgh Medical Center, Pittsburgh, PA
Prognostic Role of E-Cadherin mRNA Levels in Urothelial Carcinoma of the Bladder: Relationship with Clinical Course at 12 Years Follow-Up
(754)
G Nesi, T Cai, LR Girardi, R Bartoletti - University of Florence, Florence, Italy
Further Evidence Supporting the Concept of Alternative Target Genes Contiguous to RB1 Involved in Clonal Expansion of In Situ Urothelial Neoplasia
(716)
S Lee, T Majewski, J Jeong, A Bhattacharya, TC Kuang, K Baggerly, B Czerniak - The University of Texas M. D. Anderson Cancer Center, Houston, TX
Use of pHH3, Ki-67 and Survivin Immunoreactivity in Evaluating Urothelial Carcinomas of the Bladder
(750)
H Nakhla, O El-Zammar - State University of New York & Upstate Medical University, Syracuse, NY
ProEx™ C (Mcm2 + Topoisomerase II-a) Expression in Urinary Bladder as a Marker of Urothelial Carcinoma
(652)
HS Edmunds, V Padmanabhan - Dartmouth Hitchcock Medical Center, Lebanon, NH
KOC Is a Useful Marker for the Classification of Urothelial Neoplasms of the Bladder
(719)
L Li, R Simon, BO Spauldin, PA Bourne, JL Yao, PA di Sant’Agnese, H Xu, J Huang - University of Rochester Medical Center, Rochester, NY; Dako North America, Carpinteria, CA
Significance of Mitotic Activity and Activated Nuclear and Cytoplasmic AKT in Seminoma and Embryonal Carcinoma
(628)
JD Cass, C Wong, L Sugar, P Warde, JM Sweet - University of Toronto, Toronto, ON, Canada; University of Toronto and Radiation Medicine Program, Toronto, ON, Canada
OCT-4 Expression in Malignant Epithelial Tumors of the Genitourinary Tract
(787)
AJ Saenz, GP Nielsen, S Campbell, E Oliva - Massachusetts General Hospital and Harvard Medical School, Boston, MA
Direct Assessment of Telomeres in Testicular Germ Cell Tumors Reveals Evidence of Telomere Length Heterogeneity and Non-Telomerase Mediated Telomere Maintenance in Tumor Subsets
(739)
AK Meeker, JI Epstein, Y Konishi, GJ Netto - Johns Hopkins University School of Medicine, Baltimore, MD
Prepubertal Biopsies Predict Significance of Cryptorchidism-Associated Mixed Testicular Atrophy, Allowing Fertility Assessment
(757)
M Nistal, MM Cajaiba, ML Riestra, M Reyes-Mugica, R Paniagua - Hospital La Paz/Universidad Autonoma de Madrid, Madrid, Spain; Yale University, New Haven, CT; University of Alcala, Alcala de Henares, Spain
Rete Testis-Associated Nodular Steroid Cell Nests: Putative Pluripotential Testicular Hilus Steroid Cells or Testicular Adnexal Leydig Cells. A Report in 3 Orchiectomies with Emphasis on Differential Diagnosis
(605)
MB Amin, GP Paner - Cedars-Sinai Medical Center, Los Angeles, CA
The Spectrum of Persistence of Testicular Blastema and Ectopic Testicular Parenchyma: A Possible Result of Focal Delay in Gonadal Development
(626)
MM Cajaiba, E Garcia-Fernandez, M Reyes-Mugica, M Nistal - Hospital La Paz/Universidad Autonoma de Madrid, Madrid, Spain; Yale University School of Medicine, New Haven, CT
button next to any title to add to Itinerary Planner...
Add
